Company: CERO
Filing Date: 2025-07-18
Form Type: 8-K
Source: 0001213900-25-065655
Chunk: 1

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-18
Form: 8-K
Item: Item 3.02
Chunk 1
---
 without registration under the Securities Act, in reliance on the exemptions provided
by Section 4(a)(2) of the Securities Act of 1933, as amended (the “ Securities Act”) as a transaction not involving a public
offering and Rule 506 promulgated under the Securities Act as sales to accredited investors, and in reliance on similar exemptions under
applicable state laws.

The description of the terms and conditions of
the Securities Purchase Agreement and the Certificate of Designations do not purport to be complete and each is qualified in its entirety
by the full text of Securities Purchase Agreement and the Certificate of Designations, as applicable, which are filed as exhibits to the
Company’s Current Reports on Form 8-K filed on April 22, 2025 and June 30, 2025 as well as on April 25, 2025, respectively.

Item 9.01 Financial Statements and Exhibits.